English   Danish

2023/2024  KAN-CBIOO1009U  Innovation Challenges in BioBusiness

English Title
Innovation Challenges in BioBusiness

Course information

Language English
Course ECTS 7.5 ECTS
Type Mandatory (also offered as elective)
Level Full Degree Master
Duration One Quarter
Start time of the course Second Quarter
Timetable Course schedule will be posted at calendar.cbs.dk
Max. participants 50
Study board
Study Board for MSc. in Business Administration and Bioentrepreneurship
Course coordinator
  • Markus Simeth - Department of Strategy and Innovation (SI)
Main academic disciplines
  • Innovation
  • Strategy
Teaching methods
  • Blended learning
Last updated on 06-06-2023

Relevant links

Learning objectives
  • Account for the main terms and definitions central in economics and management of innovation
  • Describe and assess the potential for formal and informal external knowledge sourcing and how it may help the organization in its pursuit of the next generation of innovations
  • Make informed choices with respect to R&D projects
  • Reflect on how companies can effectively manage highly creative and skilled individuals, such as scientists
  • Formulate innovation based strategies in a high-tech settings and account for their use
  • Acquire professional skills in strategy formulation and innovation management
Course prerequisites
This is a mandatory course for the MSc in Business Administration and Bioentrepreneurship.

To sign up send a 1-page motivational letter and a grade transcript to ily.stu@cbs.dk before the CBS registration deadline for elective courses. You may find the registration deadlines on my.cbs.dk ( https:/​​/​​studentcbs.sharepoint.com/​​graduate/​​pages/​​registration-for-electives.aspx ). Please also remember to sign up through the online registration.
Innovation Challenges in BioBusiness:
Exam ECTS 7,5
Examination form Written sit-in exam on CBS' computers
Individual or group exam Individual exam
Assignment type Written assignment
Duration 4 hours
Grading scale 7-point grading scale
Examiner(s) One internal examiner
Exam period Autumn
Aids Limited aids, see the list below:
The student is allowed to bring
  • An approved calculator. Only the models HP10bll+ or Texas BA ll Plus are allowed (both models are non-programmable, financial calculators).
  • Language dictionaries in paper format
The student will have access to
  • Advanced IT application package
Make-up exam/re-exam
Same examination form as the ordinary exam
The number of registered candidates for the make-up examination/re-take examination may warrant that it most appropriately be held as an oral examination. The programme office will inform the students if the make-up examination/re-take examination instead is held as an oral examination including a second examiner or external examiner.
Course content, structure and pedagogical approach

The course will examine factors shaping opportunities for innovation in biobusiness, and the business implications of those opportunities. The theme of strategy choices emphasize alternatives faced by both established and emerging bio-firms and the relevant tools for strategic decision.

The course will be structured around managerial challenges firms face in the biotech, pharmaceutical and medical equipment sector, and around key products/technologies recently developed in the industry. You will work individually and in teams, in a cross-disciplinary environment and you will focus on some of the challenges humanity is facing or will face in the future. Key topics will include:


  • Strategy and conduct of bio-sector firms
  • The role of institutions (e.g. universities, regulation, intellectual property rights)
  • Corporate R&D and scientific research
  • Appropriability mechanisms
  • Markets for Technology and the sourcing of external innovation
  • Organizing for Innovation
  • The linkage between financial markets and corporate innovation
  • The role of digitalization in the life sciences
Description of the teaching methods
Teaching includes lecture-style classes, in-class workshops with students presenting and actively participating in discussions around pre-assigned cases and/or exercises, and guest presentations by academics and practitioners. This course will be offered in a blended learning format, both in-class and online. Online session can be either pre-recorded or live, or a combination of the two. Preparation before class is of crucial importance. The course integrates the Nordic 9 both in the content and the teaching methods.
Feedback during the teaching period
Feedback is given through the quizzes online and in class. Additionally, one session is dedicated to a mock-exam, followed by peer-grading and feedback from the lecturer. Students are encouraged to make use of office/consultation hours.
Student workload
lecture 40 hours
preparation 166 hours
Expected literature
  • Porter, M.E., 1996. What is strategy?. Harvard business review74(6), pp.61-78.
  • Teece D.J. 1986. Profiting from technological innovation: Implications for integration collaboration, licensing and public policy. Research Policy 15, 285-305
  • Cockburn, I.M. and Henderson, R.M. (1998). Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery. Journal of Industrial Economics, 46(2), 157–182.
  • Perkmann, M., et al. (2013). Academic engagement and commercialisation: A review of the literature on university–industry relations. Research Policy 42(2) 423-442.



Additional literature will be announced in the course syllabus.

Last updated on 06-06-2023